Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Phipps

Showing results (171-180 of 396) with videos related to

Pageof 40
Sort By:
Immunologic Research|January 1, 1990
Immune functions of subpopulations of lung fibroblastsR P Phipps, D P Penney, P Keng, et al.
Cancer Immunology, Immunotherapy : CII|August 2, 2007
Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cellsElizabeth P Ryan, Timothy P Bushnell, Alan E Friedman, et al.
Transfusion|October 11, 2014
Removal of biologic response modifiers associated with platelet transfusion reactions: strategies worth considering?Olivier Garraud, Fabrice Cognasse, Hind Hamzeh-Cognasse, et al.
The Journal of Biological Chemistry|December 25, 2014
Salinomycin and other polyether ionophores are a new class of antiscarring agentCollynn F Woeller, Charles W O'Loughlin, Elisa Roztocil, et al.
Plos One|September 20, 2019
Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptorChristine L Hammond, Elisa Roztocil, Richard P Phipps, et al.
The American Journal of Pathology|September 11, 2001
Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblastsL Koumas, A E King, H O Critchley, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 13, 2006
Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular diseaseDenise M Ray, Sherry L Spinelli, Jamie J O'Brien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particlesElizabeth P Ryan, Christine M Malboeuf, Matthew Bernard, et al.
Immunologic Research|February 3, 2009
The platelet as an immune cell-CD40 ligand and transfusion immunomodulationNeil Blumberg, Sherry L Spinelli, Charles W Francis, et al.
The Veterinary Record|December 22, 2016
Rhipicephalus sanguineus importation into the UK: surveillance, risk, public health awareness and One Health responseK M Hansford, L P Phipps, B Cull, et al.
Pageof 40

Showing results (171-180 of 396) with videos related to

Sort By:
Pageof 40
Immunologic Research|January 1, 1990
Immune functions of subpopulations of lung fibroblastsR P Phipps, D P Penney, P Keng, et al.
Cancer Immunology, Immunotherapy : CII|August 2, 2007
Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cellsElizabeth P Ryan, Timothy P Bushnell, Alan E Friedman, et al.
Transfusion|October 11, 2014
Removal of biologic response modifiers associated with platelet transfusion reactions: strategies worth considering?Olivier Garraud, Fabrice Cognasse, Hind Hamzeh-Cognasse, et al.
The Journal of Biological Chemistry|December 25, 2014
Salinomycin and other polyether ionophores are a new class of antiscarring agentCollynn F Woeller, Charles W O'Loughlin, Elisa Roztocil, et al.
Plos One|September 20, 2019
Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptorChristine L Hammond, Elisa Roztocil, Richard P Phipps, et al.
The American Journal of Pathology|September 11, 2001
Fibroblast heterogeneity: existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblastsL Koumas, A E King, H O Critchley, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 13, 2006
Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular diseaseDenise M Ray, Sherry L Spinelli, Jamie J O'Brien, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particlesElizabeth P Ryan, Christine M Malboeuf, Matthew Bernard, et al.
Immunologic Research|February 3, 2009
The platelet as an immune cell-CD40 ligand and transfusion immunomodulationNeil Blumberg, Sherry L Spinelli, Charles W Francis, et al.
The Veterinary Record|December 22, 2016
Rhipicephalus sanguineus importation into the UK: surveillance, risk, public health awareness and One Health responseK M Hansford, L P Phipps, B Cull, et al.
Pageof 40